Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...

Discover how the 340B drug pricing program, intended to help low-income patients, has become a system of abuse and misuse ...

Despite rebukes by two federal circuit courts, an HHS sub-agency continues to overstep its authority when administering a ...

Johnson & Johnson launched a legal challenge against a federal health agency blocking the company’s quest to tighten the way ...

The health tech company’s new app delivers healthcare in Spanish, boosting accessibility for millions in AmericaST. LOUIS, ...